Advertisment

The Role of Low-Inflammatory Diets in Reducing Type 2 Diabetes Risk

author-image
Zara Nwosu
New Update
NULL

The Role of Low-Inflammatory Diets in Reducing Type 2 Diabetes Risk

Advertisment

In a world grappling with a rising prevalence of type 2 diabetes (T2D), recent findings published in BMC Medicine have brought to light the potential of low-inflammatory diets in mitigating this health concern. The study underscored the correlation between low-inflammatory diets and a reduced risk of T2D, suggesting that these diets may even delay the onset of T2D by a considerable period among individuals with normoglycemia and prediabetes.

Advertisment

Unveiling the Study

The study, involving 142,271 non-diabetic participants from the United Kingdom (UK) Biobank, found that low-inflammatory diets were associated with a reduced T2D risk in a dose-dependent manner. With 126,203 normoglycemic and 16,068 prediabetic participants, the study highlighted the potential of these diets not only in T2D prevention, but also in delaying the onset of T2D by up to two years among normoglycemic individuals and 1.2 years among those with prediabetes.

Assessing the Associations

Advertisment

The research used glycated hemoglobin (HbA1c), high-sensitivity C-reactive protein (hsCRP) levels, genetic risk score (GRS), and an inflammatory diet index (IDI) to evaluate the associations between low-inflammatory diets and T2D risk. Furthermore, the study provided intriguing insights into the capacity of low-inflammatory diets to temper the risk posed by genetic factors for T2D development.

The Potential of Low-Inflammatory Diets

The findings of the study underscore the potential role of diet in preventing T2D. Adherence to low-inflammatory diets could have a significant impact on the health outcomes of individuals at risk of developing T2D. These diets could serve as a preventive strategy, especially among those with prediabetes or normoglycemia, potentially delaying the onset of T2D.

Advertisment

Additional Insights

While the study is a breakthrough in understanding the link between diet and T2D, it is crucial to note that the participants were of white British ancestry. This factor might limit the generalizability of the findings to other ethnic groups. Further research encompassing diverse population groups would be beneficial to verify these findings.

Implications for Weight Management and Glycemic Control

Advertisment

Another retrospective US study discussed on Springer emphasized the impact of weight change on glycemic control and metabolic parameters in T2D. It suggested that modest and sustained weight loss could lead to clinically meaningful improvements in glycemic and metabolic parameters among people with T2D, further emphasizing the importance of weight management in managing T2D and preventing its complications.

Exploring Further Research Avenues

Lastly, a study discussed on ScienceDirect highlighted the role of CD248 in promoting insulin resistance by binding to the insulin receptor and dampening its insulin-induced autophosphorylation. The discovery of a cell-surface CD248-IR complex accessible to pharmacologic intervention opens new research avenues toward developing agents to prevent or reverse insulin resistance, thereby further contributing to the prevention and management of T2D.

In conclusion, the recent findings on the role of low-inflammatory diets and their potential in reducing the risk of T2D offer a promising approach to diabetes prevention. However, further research is necessary to broaden the understanding of the impact of diet on T2D risk and to verify these findings across diverse populations.

Advertisment
Chat with Dr. Medriva !